r&d pipeline
guided by innovation and internationalization, fosun pharma increases its investment in r&d and the introduction of scientific research personnel, enriches its innovative product pipelines, improves its r&d and clinical trial capacities for new drugs, and speeds up the r&d and transformation of innovative technologies and products through diverse and multi-level cooperation models, such as independent r&d, co-development, in-licensing, and in-depth incubation.
major drug projects under development
as of december 31, 2021, fosun pharma had more than 240 projects under development, including innovator drugs, biosimilars, generic drugs and consistency evaluation.
-
- 27
- self-developed small molecule innovator drugs
-
- 26
- self-developed innovative biologics
-
- 11
- licensed-in innovator drugs
-
- 14
- self-developed biosimilars
-
- 25
- consistency evaluation projects